GeoVax Labs (GOVX) Revenue & Revenue Breakdown
GeoVax Labs Revenue Highlights
GeoVax Labs Revenue by Period
GeoVax Labs Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | -100.00% |
| 2022-12-31 | $81.00K | -78.96% |
| 2021-12-31 | $385.00K | -78.88% |
| 2020-12-31 | $1.82M | 55.03% |
| 2019-12-31 | $1.18M | 22.11% |
| 2018-12-31 | $963.00K | -10.44% |
| 2017-12-31 | $1.08M | 29.72% |
| 2016-12-31 | $828.92K | 93.64% |
| 2015-12-31 | $428.08K | -51.52% |
| 2014-12-31 | $882.96K | -63.48% |
| 2013-12-31 | $2.42M | -9.01% |
| 2012-12-31 | $2.66M | -45.77% |
| 2011-12-31 | $4.90M | -5.50% |
| 2010-12-31 | $5.19M | 41.36% |
| 2009-12-31 | $3.67M | 26.05% |
| 2008-12-31 | $2.91M | 1127.90% |
| 2007-12-31 | $237.00K | -72.21% |
| 2006-12-31 | $852.90K | 100.00% |
| 2005-12-31 | - | 100.00% |
| 2004-12-31 | - | 100.00% |
| 2003-12-31 | - | -100.00% |
| 2002-12-31 | $180.24K | -93.12% |
| 2001-12-31 | $2.62M | 204.73% |
| 2000-12-31 | $859.84K | -62.27% |
| 1999-12-31 | $2.28M | -57.54% |
| 1998-12-31 | $5.37M | 96.61% |
| 1997-12-31 | $2.73M | 2805.93% |
| 1996-12-31 | $93.95K | - |
GeoVax Labs generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
GeoVax Labs Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $103.91K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | -100.00% |
| 2022-12-31 | $-81.53K | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | -100.00% |
| 2022-03-31 | $81.53K | -50.58% |
| 2021-12-31 | $164.96K | 442.39% |
| 2021-09-30 | $30.41K | -61.84% |
| 2021-06-30 | $79.71K | -27.81% |
| 2021-03-31 | $110.42K | -56.12% |
| 2020-12-31 | $251.62K | -39.44% |
| 2020-09-30 | $415.46K | -5.71% |
| 2020-06-30 | $440.60K | -38.46% |
| 2020-03-31 | $715.98K | 166.64% |
| 2019-12-31 | $268.51K | -19.42% |
| 2019-09-30 | $333.21K | 58.72% |
| 2019-06-30 | $209.94K | -42.36% |
| 2019-03-31 | $364.23K | 21.70% |
| 2018-12-31 | $299.30K | -14.33% |
| 2018-09-30 | $349.34K | 274.57% |
| 2018-06-30 | $93.27K | -57.86% |
| 2018-03-31 | $221.30K | 23.35% |
| 2017-12-31 | $179.40K | -27.66% |
| 2017-09-30 | $247.99K | -29.55% |
| 2017-06-30 | $352.00K | 18.92% |
| 2017-03-31 | $296.00K | 69.21% |
| 2016-12-31 | $174.93K | -60.25% |
| 2016-09-30 | $440.11K | 164.68% |
| 2016-06-30 | $166.28K | 246.42% |
| 2016-03-31 | $48.00K | -70.01% |
| 2015-12-31 | $160.05K | 71.86% |
| 2015-09-30 | $93.13K | 30.30% |
| 2015-06-30 | $71.47K | -30.89% |
| 2015-03-31 | $103.42K | -53.64% |
| 2014-12-31 | $223.09K | -30.74% |
| 2014-09-30 | $322.09K | 78.50% |
| 2014-06-30 | $180.44K | 14.68% |
| 2014-03-31 | $157.34K | -9.96% |
| 2013-12-31 | $174.74K | -82.60% |
| 2013-09-30 | $1.00M | 127.42% |
| 2013-06-30 | $441.56K | -44.60% |
| 2013-03-31 | $797.04K | 73.43% |
| 2012-12-31 | $459.57K | -27.97% |
| 2012-09-30 | $638.00K | -9.59% |
| 2012-06-30 | $705.70K | -17.37% |
| 2012-03-31 | $854.06K | -10.74% |
| 2011-12-31 | $956.84K | -26.23% |
| 2011-09-30 | $1.30M | -26.01% |
| 2011-06-30 | $1.75M | 96.31% |
| 2011-03-31 | $893.00K | -5.63% |
| 2010-12-31 | $946.24K | -18.66% |
| 2010-09-30 | $1.16M | -33.04% |
| 2010-06-30 | $1.74M | 29.78% |
| 2010-03-31 | $1.34M | 237.43% |
| 2009-12-31 | $396.69K | -78.07% |
| 2009-09-30 | $1.81M | 140.24% |
| 2009-06-30 | $752.80K | 6.01% |
| 2009-03-31 | $710.15K | 16.11% |
| 2008-12-31 | $611.60K | -53.75% |
| 2008-09-30 | $1.32M | 251.66% |
| 2008-06-30 | $376.08K | -37.32% |
| 2008-03-31 | $599.99K | 100.00% |
| 2007-12-31 | - | - |
GeoVax Labs generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
GeoVax Labs Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ONTX | Traws Pharma | $226.00B | $56.00K |
| JAGX | Jaguar Health | $9.76M | $2.72M |
| OCGN | Ocugen | $6.04M | $1.14M |
| SONN | Sonnet BioTherapeutics | $147.81K | - |
| CYTO | Altamira Therapeutics | - | $52.73K |
| PXMD | PaxMedica | - | - |
| ZURA | Zura Bio | - | - |
| REVB | Revelation Biosciences | - | - |
| HILS | Tharimmune | - | - |
| ATNF | 180 Life Sciences | - | - |
| GOVX | GeoVax Labs | - | - |
| ATXI | Avenue Therapeutics | - | - |
| PHIO | Phio Pharmaceuticals | - | - |
| ZVSA | ZyVersa Therapeutics | - | - |
| VIRI | Virios Therapeutics | - | - |
| EFTR | eFFECTOR Therapeutics | - | - |
| QNRX | Quoin Pharmaceuticals | - | - |
| CDIO | Cardio Diagnostics | - | $7.87K |
| BWV | Onconetix | - | - |
GOVX Revenue FAQ
What is GeoVax Labs’s yearly revenue?
GeoVax Labs's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $81K, representing a decrease of -78.96% compared to 2021. GOVX's yearly revenue for 2021 was $385K, representing a decrease of -78.88% compared to 2020.
What is GeoVax Labs’s quarterly revenue?
GeoVax Labs's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). GOVX's quarterly revenue for Q4 2023 was $103.91K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is GeoVax Labs’s revenue growth rate?
GeoVax Labs's revenue growth rate for the last 3 years (2021-2023) was -100.00%, and for the last 5 years (2019-2023) was -100.00%.